Skip to contentSkip to filters

We use cookies for analytics.

FDA Grand Rounds – Pharmacovigilance in Practice: From Safety Signals to Regulatory Action

LCDR Anne Tobenkin, Pharm.D., M.S. and Leah Herity, Pharm.D., M.P.H.

Center for Drug Evaluation and Research, U.S. Food and Drug Administration

Recording

40 min

Abstract

FDA safety evaluators explain how adverse-event information becomes a regulatory action. They review three recent safety findings to show how the agency identifies and investigates potential problems with marketed medicines.

Topics